REDEFINING REGENERATION AND LONGEVITY
At Dr Kania Clinic, we believe the next evolution in regenerative and longevity medicine lies within the body’s own biology. Through a scientific collaboration with Patrick Sewell and TripleHelix Science — a global leader in gene, stem-cell, and cancer-regenerative biotechnology — we connect our patients to cutting-edge research in cellular repair, metabolic optimisation, and biological age reversal.
While Dr Kania Clinic does not perform gene or stem-cell therapies on site, we discreetly facilitate referrals and pre-assessment discussions for patients exploring legitimate, evidence-based regenerative programs conducted under international medical supervision.
ABOUT PATRICK SEWELL & TRIPLEHELIX SCIENCE
Patrick Sewell is an internationally recognised physician and biotechnology innovator whose career spans more than two decades at the intersection of clinical medicine, molecular biology, and regenerative science. Trained in interventional radiology and oncology, he has dedicated his work to developing biologically driven approaches that address disease and ageing at the cellular level.
As the Founder and Chief Scientific Officer of TripleHelix Science, Patrick leads a global multidisciplinary team of scientists, clinicians, and molecular engineers advancing the application of gene modulation, cell reprogramming, and regenerative oncology. The TripleHelix model integrates genomic insight, stem-cell technology, and precision immunology to explore how the human body can self-repair, regenerate, and extend vitality.
TripleHelix Science operates at the frontier of regenerative and longevity biotechnology, focusing on three pillars of innovation:
Cancer-Regenerative Medicine – Developing biologically supportive programs for immune recovery and cellular repair in oncology patients.
Gene and Cellular Rejuvenation – Harnessing advanced gene-editing and stem-cell strategies to restore physiological equilibrium and enhance tissue regeneration.
Longevity & Preventive Health – Using molecular diagnostics and AI-driven analytics to identify early markers of ageing and metabolic dysfunction, guiding bespoke interventions that support long-term vitality.
Dr. Patrick Sewell, MD
Through its international network of research facilities and medical partners, TripleHelix Science facilitates access to regulated clinical environments where pioneering therapies are explored under strict medical and ethical governance. Its work has been featured in global scientific forums for its leadership in translational biology, cellular optimisation, and regenerative cancer care.
Dr Kania’s collaboration with Dr Patrick Sewell reflects a shared philosophy — that responsible innovation, scientific transparency, and personalised medicine are central to the future of health optimisation. Together, they bridge clinical expertise and biotechnology, providing patients with discreet access to the most advanced regenerative programs available worldwide.
THERAPEUTIC AREAS OF INNOVATION
1. Cancer-Regenerative Science
TripleHelix pioneers cellular and immune-supportive strategies designed to complement oncology care and post-treatment recovery. Focus areas include:
Immune modulation and metabolic resilience
Stem-cell-based tissue repair post-therapy
DNA-level repair mechanisms supporting cellular function
2. Gene & Epigenetic Therapies
Exploring the controlled modulation of gene pathways to reverse molecular ageing, repair DNA damage, and enhance regenerative potential. Research includes:
Gene and mRNA signalling regulation
CRISPR-based cellular correction
Epigenetic longevity optimisation
3. Stem-Cell Regeneration
Advanced programs use autologous and mesenchymal stem cells to repair, restore, and rejuvenate tissues, improving vitality and systemic performance.
4. Longevity & Preventive Medicine
Biological age mapping, mitochondrial health diagnostics, and metabolic enhancement form the foundation of long-term regenerative wellness — an emerging frontier in personalised medicine.
DR KANIA’S ROLE
At Dr Kania Clinic, we serve as a scientific bridge for patients seeking clarity, credibility, and clinical direction in regenerative and longevity medicine.
Our role includes:
Patient education on emerging biotechnologies
Eligibility and safety pre-assessments before international referral
Continuity of care post-program through integrative longevity support
All referred programs are operated within licensed international medical environments, with strict adherence to regulatory, bioethical, and scientific standards.
ETHICAL & REGULATORY COMPLIANCE
The UK prohibits in-clinic gene or stem-cell administration outside MHRA-licensed trials. Our role is purely educational and facilitative — ensuring every patient is referred responsibly, with full understanding of program scope, scientific basis, and medical governance.
All referrals are:
Conducted through verified international partners such as TripleHelix Science
Supported by multidisciplinary oversight
In line with GMC Good Medical Practice and ASA advertising standards
Dr Kania Clinic does not supply, administer, or promote any unlicensed medical product within the UK.
LEARN MORE
Patients seeking access to advanced regenerative oncology or longevity biotechnology can learn more at www.triplehelixscience.com. To discuss suitability or obtain a preliminary consultation, please contact Dr Kania Clinic in Belgravia / Knightsbridge, London.
(Referrals are discretionary and subject to comprehensive health assessment and international regulatory frameworks.)